May 2
|
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
|
May 2
|
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
|
May 2
|
Novo sees Wegovy sales dip on lower price, tight supply
|
May 2
|
Eli Lilly and Company (NYSE:LLY) Just Released Its First-Quarter Earnings: Here's What Analysts Think
|
May 2
|
Here's Why Eli Lilly Stock Remains a Screaming Buy
|
May 2
|
UPDATE 7-Novo Nordisk trims price for blockbuster obesity drug as competition heats up
|
May 2
|
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
|
May 2
|
FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
|
May 1
|
Danish Medicines Agency Says Type 2 Diabetes Patients Should Start Treatment With 'Cheaper' Drugs
|
May 1
|
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
|
May 1
|
Amazon, AMD, and Super Micro Sing the Same Sad Song, and 5 Other Things to Know Before Markets Open.
|
May 1
|
3 stocks with the biggest gains took April's biggest losses
|
May 1
|
Company News for May 1, 2024
|
May 1
|
Q1 2024 Eli Lilly and Co Earnings Call
|
May 1
|
Eli Lilly and Co (LLY) Q1 2024 Earnings Call Transcript Highlights: Stellar Growth and ...
|
May 1
|
This Options-Backed Strategy Can Help You Dodge the Stock Market’s Hazards
|
May 1
|
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
|
Apr 30
|
These 3 Companies Recently Lifted Guidance
|
Apr 30
|
Dow Jones Futures: Stock Market Skids Into Fed; Amazon Rises Late As AMD, Super Micro Plunge
|
Apr 30
|
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
|